Cisplatin Plus Temozolomide Compared With Temozolomide in Patients With MGMT Promotor Unmethylated Glioblastoma

NCT06186440 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma Multiforme of Brain

Interventions

DRUG: Cisplatin Plus Temozolomide
DRUG: Temozolomide

Sponsor

Zhongnan Hospital